Exact Mass: 318.1368

Exact Mass Matches: 318.1368

Found 23 metabolites which its exact mass value is equals to given mass value 318.1368, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Nile red

8-(diethylamino)-12H-10-oxa-5-azatetraphen-12-one

C20H18N2O2 (318.1368)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes

   
   
   
   

2-benzyl-1,2,3,4-tetrahydro-benzo[b][1,6]naphthyridine-10-carboxylic acid

2-benzyl-1,2,3,4-tetrahydro-benzo[b][1,6]naphthyridine-10-carboxylic acid

C20H18N2O2 (318.1368)


   

1-[2-(2,3-dihydroindol-1-yl)-2-oxoethyl]-2-methylindole-3-carbaldehyde

1-[2-(2,3-dihydroindol-1-yl)-2-oxoethyl]-2-methylindole-3-carbaldehyde

C20H18N2O2 (318.1368)


   
   

4-METHYL-N-(4-NITROPHENYL)-N-(P-TOLYL)ANILINE

4-METHYL-N-(4-NITROPHENYL)-N-(P-TOLYL)ANILINE

C20H18N2O2 (318.1368)


   

(6-Butyl-5-decen-5-yl)-λ2-stannane

(6-Butyl-5-decen-5-yl)-λ2-stannane

C14H30Sn (318.1369)


   

1-(TERT-BUTOXYCARBONYL)-2-(4-CYANOPHENYL)INDOLE

1-(TERT-BUTOXYCARBONYL)-2-(4-CYANOPHENYL)INDOLE

C20H18N2O2 (318.1368)


   

Quinelorane hydrochloride

Quinelorane hydrochloride

C14H24Cl2N4 (318.1378)


D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist

   

2-Acetamido-3-[(4-hydroxy-1-oxononan-3-yl)sulfanyl]propanoate

2-Acetamido-3-[(4-hydroxy-1-oxononan-3-yl)sulfanyl]propanoate

C14H24NO5S- (318.1375)


   

N-methyl-N-[4-[(2-oxo-1-naphthalenylidene)methylamino]phenyl]acetamide

N-methyl-N-[4-[(2-oxo-1-naphthalenylidene)methylamino]phenyl]acetamide

C20H18N2O2 (318.1368)


   

4-methyl-N-[(1-naphthylacetyl)oxy]benzenecarboximidamide

4-methyl-N-[(1-naphthylacetyl)oxy]benzenecarboximidamide

C20H18N2O2 (318.1368)


   

(2S,3R,4S)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-2-azetidinecarbonitrile

(2S,3R,4S)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-2-azetidinecarbonitrile

C20H18N2O2 (318.1368)


   

(2R,3R,4R)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]azetidine-2-carbonitrile

(2R,3R,4R)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]azetidine-2-carbonitrile

C20H18N2O2 (318.1368)


   

(2S,3S,4S)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-2-azetidinecarbonitrile

(2S,3S,4S)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-2-azetidinecarbonitrile

C20H18N2O2 (318.1368)


   

(3Z)-2-(4-methoxybenzyl)-3-(4-methoxybenzylidene)butanedinitrile

(3Z)-2-(4-methoxybenzyl)-3-(4-methoxybenzylidene)butanedinitrile

C20H18N2O2 (318.1368)


   
   

NK372135A

NK372135A

C20H18N2O2 (318.1368)


A dinitrile that is butanedinitrile substituted by 4-methoxybenzyl and 4-methoxybenzylidene groups at positions 2 and 3 respectively. Isolated from the culture broth of the fungus Neosartorya fischeri, it exhibits antifungal activity.

   

SLMP53-1

SLMP53-1

C20H18N2O2 (318.1368)


SLMP53-1 is a wild-type and mutant p53 reactivator with promising antitumor activity. SLMP53-1 mediates the reprograming of glucose metabolism in cancer cells. SLMP53-1 depletes angiogenesis, decreasing endothelial cell tube formation and vascular endothelial growth factor (VEGF) expression levels[1][2].

   

2,2-bis(1h-indol-3-yl)ethyl acetate

2,2-bis(1h-indol-3-yl)ethyl acetate

C20H18N2O2 (318.1368)